Search results for "Diabetes"


 
Results 111 - 120 of about 963 for "Diabetes".
Sort by: Relevance | Newest | Oldest

More compounded products recalled, diabetes drug approved

This regulatory update covers a recall of a compounding pharmacy's products due to mold and approval of a sodium-glucose co-transporter for diabetes.
https://immattersacp.org/archives/2013/06/fda.htm
1 Jun 2013

USPSTF lowers age for starting diabetes screening from 40 to 35 years

Primary care clinicians should screen all overweight or obese adults ages 35 to 70 years for diabetes and prediabetes and should offer interventions for those with either condition, the U.S. Preventive Services Task Force (USPSTF) recently recommended.
https://immattersacp.org/weekly/archives/2021/08/31/2.htm
31 Aug 2021

Early Bird rates extended for ACP's Internal Medicine Meeting 2022

The new registration deadline to receive the discounted rate is Feb. 28.
https://immattersacp.org/weekly/archives/2022/02/08/5.htm
8 Feb 2022

New diabetes drug, new indication for eosinophilic esophagitis

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/07/new-diabetes-drug-new-indication-for-eosinophilic-esophagitis.htm
1 Jul 2022

MKSAP Quiz: Routine follow-up appointment with schizophrenia

A 56-year-old man is evaluated during a routine follow-up appointment. He has schizophrenia treated with olanzapine. Currently, the patient experiences no hallucinations or delusions. He is otherwise healthy. Following a physical exam, what should also be monitored in this patient?
https://immattersacp.org/weekly/archives/2021/10/26/3.htm
26 Oct 2021

Watch out for NAFLD, treat ASAP

While nonalcoholic fatty liver disease and nonalcoholic steatohepatitis are dynamic processes that can progress and regress, lifestyle modification, including diet, is a must for all patients, wherever they are in their disease.
https://immattersacp.org/archives/2021/04/watch-out-for-nafld-treat-asap.htm
1 Apr 2021

ACE inhibitors, ARBs most effective against ESRD in patients with diabetes, kidney disease

However, no regimen to lower blood pressure seems to prolong survival, a recent analysis has found.
https://immattersacp.org/weekly/archives/2015/06/02/1.htm
2 Jun 2015

MKSAP Quiz: Evaluation for newly developed ascites

A 50-year-old man is evaluated for newly developed ascites. He has cirrhosis due to nonalcoholic steatohepatitis. Following a physical exam and lab studies, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2021/08/31/3.htm
31 Aug 2021

Hydrochlorothiazide no better than placebo for preventing kidney stone recurrence

A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
https://immattersacp.org/weekly/archives/2023/03/07/1.htm
7 Mar 2023

Managing diabetes meds more complicated in elderly patients

This issue covers topics including management of diabetes in the elderly, the public release of Medicare payments to physicians, and new approaches to antivirals as flu season begins.
https://immattersacp.org/archives/2014/10/editors.htm
1 Oct 2014

Result Page: Prev   7   8   9   10   11   12   13   14   15   16   Next